SECreport

Form 4 ADIAL PHARMACEUTICALS, For: Mar 25 Filed by: Gilliland Robertson H.

Adial Pharmaceuticals, Inc  (ADIL) 
US:NASDAQ Investor Relations: adialpharma.com